Method of treating thromboembolic disorders by administration of diglycosylated t-PA variants
US5242688A · kind A · utility
11Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 24, 1990 |
| Grant date | Sep 7, 1993 |
| Priority date | — |
| Expiry date | Dec 24, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating thromboembolic disorders with the diglycosylated form of a tissue plasminogen activator derivative that lacks the Finger, EGF and Kringle I domains of the native tissue plasminogen activator molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.